Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1997-02-03
1998-05-19
MacMillan, Keith
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
A61K 3160
Patent
active
057537062
ABSTRACT:
Methods of controlling phosphate metabolism and metabolic acidosis in patients suffering from renal failure and associated hyperphosphatemia or patients predisposed to development of a hyperphosphatemic condition are provided. The method in accordance with this invention comprises administering to a patient a ferric-containing compound selected from the group consisting of ferric citrate, ferric acetate, and combinations thereof. Therapeutic benefit can be realized in accordance with such method by administering the compound orally to a patient to contact and bind with ingested phosphate in the patient's digestive tract, and thereby prevent its intestinal absorption.
REFERENCES:
Chemical Abstract An 1995:828125, Kuroda et al, 1995.
Almaden, Y. et al., Am. Soc. Nephrol 6:957 (1995).
Brock, J. et al., J. Pediat 4:442-453 (1934).
Coburn, J.W. et al., Kidney Int 3:264-272 (1973).
Cox, G. et al., J. Biol. Chem 92:Xi-Xii (1931).
Deobald, H. et al., Am. J. Physiol. 111:118-123 (1935).
Gimenez, L. et al., Kidney Int 22:36-41 (1982).
Haut, L.L., Kidney Int 17:722-731 (1980).
Hollis B.W. et al., Clin. Chem. 32:2060-2063 (1986).
Hou, S.H. et al., Am. J. Kidney Dis 18:217-224 (1991).
Hsu, C., et al., Kidney Int 25:789-795 (1984).
Hsu, C.H. et al., Kidney Int 37:44-50 (1990).
Karlinsky, D. et al., Kidney Int 17:293-302 (1980).
Kilav, R. et al., J. Clin. Invest 96:327-333 (1995).
Lakshmanan, F.L. et al., Am. J. Clin. Nutr. 1368-1379 (1984).
Lau, K., Kidney Int 36:918-937 (1989).
Liu, S.H., et al., Medicine, Baltimore 22:103-161 (1943).
Lopez-Hilker, S. et al., Am. J. Physiol 259:F432-437 (1990).
Lumlertgul, D. et al., Kidney Int 29:658-666 (1986).
Martis, L., et al., Perit Dial Int 9:325-328 (1989).
Matkovic, V. et al., Am. J. Clin. Nutr. 55:992-996 (1992).
Naveh-Many, T. et al., Am. Soc. Nephrol 6:968 (1995).
Piraino, B. et al., Clin. Nephrol 37:48-51 (1992).
Portale, A.A. et al., J. Clin. Invest 73:1580-1589 (1989).
Ramirez, J.A. et al., Kidney Int 30:753-759 (1986).
Rehm, P. et al., J. Nutrition 19:213-222 (1940).
Reinhardt, T.A. et al., J. Clin. Endocrinol Metab 58(1):91-98 (1984).
Slaptopolsky, E. et al., J. Clin. Invest 50:492-499 (1971).
Slatopolsky, E. et al., Am. Soc. Nephrol 6:971 (1995).
Clarkson, E.M. et al., Clin. Sci. 30:425-438 (1966).
Coburn, J.W. et al., Kidney Int 4:96-104 (1973).
Lau, K. et al., Fluids And Electrolytes, W.B. Saunders Company, Second Edition, Philadelphia, Ch. 8-pp. 505-571 (1990).
LandOfFree
Methods for treating renal failure does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for treating renal failure, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treating renal failure will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1853585